# FAAH

## Overview
The FAAH gene encodes the enzyme fatty acid amide hydrolase, a crucial component of the endocannabinoid system. This enzyme is categorized as a hydrolase and is primarily responsible for the degradation of fatty acid amides, including the endocannabinoid anandamide (AEA), within the brain and other tissues (Ahmadalipour2020The; Hillard2012Contributions). FAAH is an integral membrane protein that functions as a homodimer, with its activity localized mainly in the endoplasmic reticulum. The enzyme's role in hydrolyzing AEA and other N-acylethanolamines is vital for regulating their signaling pathways, thereby influencing various physiological processes such as mood, anxiety, and stress responses (Dincheva2015FAAH; Hillard2012Contributions). Genetic variations in the FAAH gene, such as the C385A polymorphism, can significantly impact enzyme activity and endocannabinoid signaling, with implications for emotional regulation and potential links to psychiatric disorders (Dincheva2015FAAH; Hillard2012Contributions).

## Structure
The human FAAH protein is an integral membrane enzyme involved in the hydrolysis of fatty acid amides. Its primary structure consists of 579 amino acids, with a predicted transmembrane domain located between amino acids 9 to 29, anchoring the protein to cellular membranes (Labar2007Fatty; Patricelli1998Comparative). The secondary structure includes a twisted beta-sheet of eleven mixed strands surrounded by alpha-helices, forming a common core fold (Labar2007Fatty). The tertiary structure is characterized by a globular shape with a catalytic triad composed of Ser 241, Lys 142, and Ser 217, which are crucial for its enzymatic activity (Morgillo2022Molecular; Labar2007Fatty).

FAAH functions as a homodimer, representing its quaternary structure, with each subunit containing channels for substrate entry and product exit (Labar2007Fatty; Dainese2020The). The transmembrane domain plays a significant role in oligomerization, influencing the formation of SDS-resistant oligomers (Patricelli1998Comparative). The enzyme's structure allows for allosteric regulation, with inter-subunit communication facilitated by specific residues such as W445 (Dainese2020The).

## Function
The FAAH gene encodes the enzyme fatty acid amide hydrolase, which plays a crucial role in the degradation of endocannabinoids, such as anandamide (AEA), within the brain and other tissues. FAAH is primarily active in the endoplasmic reticulum, where it hydrolyzes AEA and other N-acylethanolamines, thus regulating their signaling and maintaining synaptic balance (Ahmadalipour2020The; Hillard2012Contributions). This enzymatic activity is essential for modulating various physiological processes, including mood, anxiety, and stress responses, by controlling the levels of endocannabinoids that bind to cannabinoid receptors (Dincheva2015FAAH; Hillard2012Contributions).

In healthy human cells, FAAH's regulation of endocannabinoid levels influences behaviors related to arousal, alertness, and anxiety, and is implicated in the modulation of energy balance, glucose/lipid metabolism, and blood pressure (Sarzani2008A; Ahmadalipour2020The). Genetic variations in the FAAH gene, such as the C385A polymorphism, can lead to altered enzyme activity and endocannabinoid signaling, impacting emotional regulation and potentially contributing to psychiatric disorders (Dincheva2015FAAH; Hillard2012Contributions).

## Clinical Significance
Mutations and alterations in the FAAH gene have been linked to various diseases and conditions. The FAAH C385A single nucleotide polymorphism (SNP) is associated with reduced FAAH expression and activity, leading to increased levels of the endocannabinoid anandamide. This variant is linked to decreased anxiety-like behaviors, improved fear extinction learning, and enhanced fronto-amygdala connectivity, suggesting potential therapeutic targets for anxiety disorders (Dincheva2015FAAH; GunduzCinar2012Convergent). 

The same SNP is also associated with increased risk for substance use disorders, including alcohol use disorder and cannabis dependence, due to its impact on endocannabinoid metabolism (Silva2023FAAH; Navarrete2022Biomarkers). The FAAH P129T mutation, resulting from the c.385 C>A change, has been linked to drug addiction, with a higher prevalence in individuals with multiple drug addictions (Flanagan2006The).

In the context of obesity, the FAAH C385A SNP is associated with a higher frequency of the A allele in overweight and obese individuals, although it is not significantly linked to binge eating disorder (Monteleone2008The). Additionally, the FAAH rs324420 polymorphism is linked to increased risk of generalized epilepsy and altered pain sensitivity, particularly in response to cold pain (Silva2023FAAH).

## Interactions
FAAH (fatty acid amide hydrolase) is involved in several interactions with other proteins, primarily within the endocannabinoid system. FAAH interacts with fatty acid binding proteins (FABPs), which transport anandamide (AEA) to FAAH for degradation. This interaction is crucial for the regulation of AEA levels, as FABPs facilitate the delivery of AEA to FAAH, where it is broken down into arachidonic acid and ethanolamine (Deutsch2016A).

FAAH also forms homodimers, which are essential for its allosteric behavior. The enzyme's dimeric form allows for functional communication between its monomers, with specific residues such as W445 playing a critical role in inter-subunit interactions. This residue is involved in forming hydrogen bonds that are crucial for the enzyme's allosteric function, affecting substrate accessibility and enzyme activity (Dainese2020The).

FAAH's interaction with the endoplasmic reticulum is facilitated by its membrane binding cap, which is formed by hydrophobic residues. This structural feature is important for FAAH's localization and function within the cell (Haq2020An). However, there is no specific information on FAAH's direct physical interactions with nucleic acids.


## References


[1. (Morgillo2022Molecular) Carmine Marco Morgillo, Antonio Lupia, Alessandro Deplano, Luciano Pirone, Bianca Fiorillo, Emilia Pedone, F. Javier Luque, Valentina Onnis, Federica Moraca, and Bruno Catalanotti. Molecular basis for non-covalent, non-competitive faah inhibition. International Journal of Molecular Sciences, 23(24):15502, December 2022. URL: http://dx.doi.org/10.3390/ijms232415502, doi:10.3390/ijms232415502. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms232415502)

[2. (Sarzani2008A) R. Sarzani, M. Bordicchia, F. Salvi, G. Cola, E. Franchi, I. Battistoni, L. Mancinelli, A. Giovagnoli, P. Dessi-Fulgheri, and A. Rappelli. A human fatty acid amide hydrolase (faah) functional gene variant is associated with lower blood pressure in young males. American Journal of Hypertension, 21(8):960–963, August 2008. URL: http://dx.doi.org/10.1038/ajh.2008.198, doi:10.1038/ajh.2008.198. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/ajh.2008.198)

[3. (Labar2007Fatty) Geoffray Labar and Catherine Michaux. Fatty acid amide hydrolase: from characterization to therapeutics. Chemistry &amp; Biodiversity, 4(8):1882–1902, August 2007. URL: http://dx.doi.org/10.1002/cbdv.200790157, doi:10.1002/cbdv.200790157. This article has 69 citations.](https://doi.org/10.1002/cbdv.200790157)

[4. (Dainese2020The) Enrico Dainese, Sergio Oddi, Monica Simonetti, Annalaura Sabatucci, Clotilde B. Angelucci, Alice Ballone, Beatrice Dufrusine, Filomena Fezza, Gianni De Fabritiis, and Mauro Maccarrone. The endocannabinoid hydrolase faah is an allosteric enzyme. Scientific Reports, February 2020. URL: http://dx.doi.org/10.1038/s41598-020-59120-1, doi:10.1038/s41598-020-59120-1. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-59120-1)

[5. (Flanagan2006The) Jonathan M. Flanagan, Alexandra L. Gerber, Jean Lud Cadet, Ernest Beutler, and Jack C. Sipe. The fatty acid amide hydrolase 385 a/a (p129t) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction. Human Genetics, 120(4):581–588, September 2006. URL: http://dx.doi.org/10.1007/s00439-006-0250-x, doi:10.1007/s00439-006-0250-x. This article has 77 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-006-0250-x)

[6. (Hillard2012Contributions) C.J. Hillard, K.M. Weinlander, and K.L. Stuhr. Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. Neuroscience, 204:207–229, March 2012. URL: http://dx.doi.org/10.1016/j.neuroscience.2011.11.020, doi:10.1016/j.neuroscience.2011.11.020. This article has 147 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.neuroscience.2011.11.020)

[7. (Monteleone2008The) Palmiero Monteleone, Alfonso Tortorella, Vassilis Martiadis, Carmela Di Filippo, Benedetta Canestrelli, and Mario Maj. The cdna 385c to a missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (faah) is associated with overweight/obesity but not with binge eating disorder in overweight/obese women. Psychoneuroendocrinology, 33(4):546–550, May 2008. URL: http://dx.doi.org/10.1016/j.psyneuen.2008.01.004, doi:10.1016/j.psyneuen.2008.01.004. This article has 52 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.psyneuen.2008.01.004)

[8. (Ahmadalipour2020The) Ali Ahmadalipour, Leila Mehdizadeh Fanid, Narges Zeinalzadeh, Maedeh Alizadeh, Helaleh Vaezi, Zahra Hassanpour Aydinlou, and Seyed Gholamreza Noorazar. The first evidence of an association between a polymorphism in the endocannabinoid-degrading enzyme faah (faah rs2295633) with attention deficit hyperactivity disorder. Genomics, 112(2):1330–1334, March 2020. URL: http://dx.doi.org/10.1016/j.ygeno.2019.07.024, doi:10.1016/j.ygeno.2019.07.024. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ygeno.2019.07.024)

[9. (Navarrete2022Biomarkers) Francisco Navarrete, María S. García-Gutiérrez, Ani Gasparyan, Daniela Navarro, Francisco López-Picón, Álvaro Morcuende, Teresa Femenía, and Jorge Manzanares. Biomarkers of the endocannabinoid system in substance use disorders. Biomolecules, 12(3):396, March 2022. URL: http://dx.doi.org/10.3390/biom12030396, doi:10.3390/biom12030396. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom12030396)

[10. (Silva2023FAAH) Hugo-Henrique Silva, Valéria Tavares, Beatriz Neto, Fátima Cerqueira, Rui Medeiros, and Maria-Raquel Silva. Faah rs324420 polymorphism: biological pathways, impact on elite athletic performance and insights for sport medicine. Genes, 14(10):1946, October 2023. URL: http://dx.doi.org/10.3390/genes14101946, doi:10.3390/genes14101946. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes14101946)

[11. (Deutsch2016A) Dale G. Deutsch. A personal retrospective: elevating anandamide (aea) by targeting fatty acid amide hydrolase (faah) and the fatty acid binding proteins (fabps). Frontiers in Pharmacology, October 2016. URL: http://dx.doi.org/10.3389/fphar.2016.00370, doi:10.3389/fphar.2016.00370. This article has 66 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2016.00370)

[12. (Haq2020An) Imdadul Haq and Aruna Kilaru. An endocannabinoid catabolic enzyme faah and its paralogs in an early land plant reveal evolutionary and functional relationship with eukaryotic orthologs. Scientific Reports, February 2020. URL: http://dx.doi.org/10.1038/s41598-020-59948-7, doi:10.1038/s41598-020-59948-7. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-59948-7)

[13. (GunduzCinar2012Convergent) O Gunduz-Cinar, K P MacPherson, R Cinar, J Gamble-George, K Sugden, B Williams, G Godlewski, T S Ramikie, A X Gorka, S O Alapafuja, S P Nikas, A Makriyannis, R Poulton, S Patel, A R Hariri, A Caspi, T E Moffitt, G Kunos, and A Holmes. Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Molecular Psychiatry, 18(7):813–823, June 2012. URL: http://dx.doi.org/10.1038/mp.2012.72, doi:10.1038/mp.2012.72. This article has 243 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/mp.2012.72)

[14. (Dincheva2015FAAH) Iva Dincheva, Andrew T. Drysdale, Catherine A. Hartley, David C. Johnson, Deqiang Jing, Elizabeth C. King, Stephen Ra, J. Megan Gray, Ruirong Yang, Ann Marie DeGruccio, Chienchun Huang, Benjamin F. Cravatt, Charles E. Glatt, Matthew N. Hill, B. J. Casey, and Francis S. Lee. Faah genetic variation enhances fronto-amygdala function in mouse and human. Nature Communications, March 2015. URL: http://dx.doi.org/10.1038/ncomms7395, doi:10.1038/ncomms7395. This article has 219 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms7395)

[15. (Patricelli1998Comparative) Matthew P. Patricelli, Hilal A. Lashuel, Dan K. Giang, Jeffery W. Kelly, and Benjamin F. Cravatt. Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerization. Biochemistry, 37(43):15177–15187, October 1998. URL: http://dx.doi.org/10.1021/bi981733n, doi:10.1021/bi981733n. This article has 128 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi981733n)